Integra Lifesciences Holdings IART
NASDAQ IART
$16.59 -0.65 (-3.77%)
At close: Aug 20, 2026 · 4:00 PM EDT

Integra Lifesciences Holdings (IART) Operating Leases (2019 - 2026)

Integra Lifesciences Holdings (IART) posted Operating Leases of $176.6 million for Q2 2026, up 1.45% sequentially from $174.0 million in Q1 2026, and up 1.81% YoY from $173.4 million in Q2 2025.

Integra Lifesciences Holdings (IART) Operating Leases (2019 - 2026) Analysis & Trends

Integra Lifesciences Holdings has reported Operating Leases for 8 years, with the latest figure at $176.6 million in Q2 2026.

  • Quarterly Operating Leases rose 1.81% year-over-year to $176.6 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $176.6 million (up 1.81% YoY) and the FY2025 annual result came in at $177.1 million, down 2.42% from the prior year.
  • Operating Leases climbed to $176.6 million in Q2 2026 per IART's latest filing, from $174.0 million in the prior quarter.
  • Over five years, Operating Leases peaked at $186.4 million in Q1 2024 and troughed at $102.1 million in Q1 2022.
  • A 5-year average of $172.7 million and a median of $175.2 million in 2025 frame the typical range for Operating Leases.
  • The sharpest annual moves came in 2022 and 2023: Operating Leases decreased 6.71% in 2022, then soared 68.16% in 2023.
  • Over 5 years, Operating Leases stood at $172.0 million in 2022, then rose by 5.86% to $182.1 million in 2023, then declined by 0.36% to $181.5 million in 2024, then declined by 2.42% to $177.1 million in 2025, then retreated by 0.28% to $176.6 million in 2026.
  • According to Business Quant data, Operating Leases over the past three periods registered $176.6 million, $174.0 million, and $177.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn
10 Integra Lifesciences Holdings 1.28 Bn 1.01 Bn 219.74 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 176.58 Mn
Mar 31, 2026 174.05 Mn
Dec 31, 2025 177.08 Mn
Sep 30, 2025 174.76 Mn
Jun 30, 2025 173.45 Mn
Mar 31, 2025 175.65 Mn
Dec 31, 2024 181.47 Mn
Sep 30, 2024 182.85 Mn
Jun 30, 2024 184.17 Mn
Mar 31, 2024 186.39 Mn
Dec 31, 2023 182.13 Mn
Sep 30, 2023 182.48 Mn
Jun 30, 2023 174.16 Mn
Mar 31, 2023 171.70 Mn
Dec 31, 2022 172.04 Mn
Sep 30, 2022 171.02 Mn
Jun 30, 2022 166.77 Mn
Mar 31, 2022 102.11 Mn
Dec 31, 2021 105.10 Mn
Sep 30, 2021 108.37 Mn